Health economic analysis of PENELOPE trial
Third-party funded project
Project title Health economic analysis of PENELOPE trial
Principal Investigator(s) Schwenkglenks, Matthias
Organisation / Research unit Departement Public Health / Pharmazeutische Medizin (Szucs)
Project Website
Project start 01.09.2013
Probable end 31.12.2022
Status Active

Health economic evaluation alongside the randomised controlled PENELOPE trial. PENELOPE is a phase III trial of palbociclib (PD-0332991) in patients with hormon receptor positive, HER2 negative patients with primary breast cancer and a high risk of recurrence after neoadjuvant chemotherapy.

Keywords health economic analysis, cost-effectiveness, breast cancer, chemotherapy
Financed by Other sources

MCSS v5.8 PRO. 0.489 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |